Eric Francis Yves Thepaut - 02 May 2023 Form 4 Insider Report for BOSTON SCIENTIFIC CORP (BSX)

Role: EVP & Pres, Eur, Mid-East, Afr
Signature: /s/ Susan Thompson, Attorney-in-Fact
Issuer symbol: BSX
Transactions as of: 02 May 2023
Net transactions value: -$3,981,975
Form type: 4
Filing time: 03 May 2023, 16:56:29 UTC
Previous filing: 22 Feb 2023
Next filing: 02 Jan 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BSX	Common Stock	Options Exercise	$395,568	+30,688	+47%	$12.89	95,670	02 May 2023	Direct
transaction	BSX	Common Stock	Sale	$4,377,543	-83,401	-87%	$52.49	12,269	02 May 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BSX	Stock Option (Right to Buy)	Options Exercise	$0	-30,688	-100%	$0.000000^*	0	02 May 2023	Common Stock	30,688	$12.89	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $52.46 to $52.52, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F2	Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on December 1, 2015, the first anniversary of the date of grant.